Dld Asset Management, LP Otonomy, Inc. Transaction History

Dld Asset Management, LP

  • $161 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 14, 2018
SELL
$4.05 - $6.1 $2.07 Million - $3.11 Million
-510,000 Closed
0 $0
Q4 2017

Feb 12, 2018
BUY
$2.8 - $5.55 $748,720 - $1.48 Million
267,400 Added 110.22%
510,000 $2.83 Million
Q3 2017

Nov 13, 2017
BUY
$3.2 - $20.8 $776,320 - $5.05 Million
242,600
242,600 $788,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email